For research teamsHelp me find a study
Back to all studies
CompletedNCT06384157

Safety and Efficacy of INDV-2000 Over 3 Months for Addiction

This study is completed in the United States. It is testing Safety and Efficacy of INDV-2000 Over 3 Months for Addiction.

AddictionBehavioralFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether INDV-2000 may be useful for adults experiencing addiction.

What would participation involve?

Participants may receive INDV-2000, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with addiction.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 10, 2024
Recruitment status
Completed
Enrollment listed in the registry
300
Sponsor
Indivior Inc.
Sponsor type
Other organization
Study type
Behavioral
Intervention type
Medication / drug, OTHER
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06384157
Official title
A Phase II Double Blind, Placebo Controlled, Randomised, Dose-Ranging Study to Assess the Safety and Efficacy of INDV-2000 Over 3 Months in Treatment Seeking Individuals With Opioid Use Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06384157. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 35 sites
  • Boyett Health Services Inc
    Hamilton, Alabama
    Site status: Not listed — confirm with the team
  • Elite Clinical Studies, LLC
    Phoenix, Arizona
    Site status: Not listed — confirm with the team
  • North County Clinical Research
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Empire Clinical Research
    Pomona, California
    Site status: Not listed — confirm with the team
  • Artemis Institute For Clinical Research - San Diego
    San Diego, California
    Site status: Not listed — confirm with the team
  • Imagine Research of Palm Beach County
    Boynton Beach, Florida
    Site status: Not listed — confirm with the team
  • Bold City Clinical Research
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Vitalix Kissimmee
    Kissimmee, Florida
    Site status: Not listed — confirm with the team
  • Accel Research Sites - Lakeland
    Lakeland, Florida
    Site status: Not listed — confirm with the team
  • Quantum Clinical Trials
    Miami Beach, Florida
    Site status: Not listed — confirm with the team
  • Segal Trials Miami Lakes
    Miami Lakes, Florida
    Site status: Not listed — confirm with the team
  • Clinical Research Center of Florida
    Pompano Beach, Florida
    Site status: Not listed — confirm with the team
  • Agile Clinical Research Trials
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Maryland Treatment Centers
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Vitalix Clinical
    Worcester, Massachusetts
    Site status: Not listed — confirm with the team
  • Insight Research Institute
    Flint, Michigan
    Site status: Not listed — confirm with the team
  • Precise Research Centers
    Flowood, Mississippi
    Site status: Not listed — confirm with the team
  • Arch Clinical Trials
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • IMA Clinical Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Oasis Clinical Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Richmond Behavioral Associates
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Dr Vando Medical Services
    The Bronx, New York
    Site status: Not listed — confirm with the team
  • Monroe Biomedical Research
    Monroe, North Carolina
    Site status: Not listed — confirm with the team
  • West Clinical Research
    Morehead City, North Carolina
    Site status: Not listed — confirm with the team
  • Midwest Clinical Research Center, LLC
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Pahl Pharmaceutical Professionals, LLC
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • SP Research PLLC Rivus Wellness and Research Insitute
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Unity Clinical Research
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Prisma Health Addiction Medicine Center
    Greenville, South Carolina
    Site status: Not listed — confirm with the team
  • Insite Clinical Research, LLC
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • El Paso Clinical Trials
    El Paso, Texas
    Site status: Not listed — confirm with the team
  • HD Research
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Progressive Clinical Research Llc
    Bountiful, Utah
    Site status: Not listed — confirm with the team
  • Alpine Research Organisation
    Clinton, Utah
    Site status: Not listed — confirm with the team
  • Boeson Clinical Research
    Provo, Utah
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving INDV-2000, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Are there criteria about substance use or wanting to reduce it?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Indivior Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.